ICU Medical (NASDAQ:ICUI – Get Rating) issued an update on its FY 2022 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $6.20-$6.80 for the period, compared to the consensus estimate of $9.17. The company issued revenue guidance of -.
ICU Medical Trading Down 0.9 %
ICUI stock traded down $1.49 during mid-day trading on Tuesday, reaching $155.89. 2,098 shares of the stock traded hands, compared to its average volume of 233,627. The stock's fifty day moving average is $169.16 and its 200-day moving average is $193.86. The company has a current ratio of 2.45, a quick ratio of 1.25 and a debt-to-equity ratio of 0.78. The company has a market cap of $3.73 billion, a P/E ratio of 371.41 and a beta of 0.57. ICU Medical has a 52-week low of $155.34 and a 52-week high of $282.00.
Get
ICU Medical alerts:
ICU Medical (NASDAQ:ICUI – Get Rating) last issued its quarterly earnings data on Monday, August 8th. The medical instruments supplier reported $1.37 earnings per share for the quarter, missing the consensus estimate of $1.68 by ($0.31). The business had revenue of $561.00 million for the quarter, compared to the consensus estimate of $569.30 million. ICU Medical had a net margin of 0.31% and a return on equity of 6.97%. ICU Medical's revenue was up 74.4% compared to the same quarter last year. During the same period in the previous year, the business posted $1.57 EPS. As a group, sell-side analysts expect that ICU Medical will post 5.23 earnings per share for the current year.
Analysts Set New Price Targets
ICUI has been the topic of several analyst reports. StockNews.com upgraded ICU Medical from a sell rating to a hold rating in a report on Monday. TheStreet downgraded shares of ICU Medical from a b- rating to a c rating in a research note on Wednesday, May 11th. KeyCorp decreased their price target on shares of ICU Medical from $230.00 to $225.00 in a research note on Tuesday, August 9th. Finally, Raymond James decreased their price target on shares of ICU Medical from $208.00 to $190.00 and set an outperform rating on the stock in a research note on Tuesday, August 9th.
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. increased its position in ICU Medical by 8.8% in the first quarter. Vanguard Group Inc. now owns 2,122,104 shares of the medical instruments supplier's stock worth $472,466,000 after purchasing an additional 171,851 shares during the period. Wellington Management Group LLP lifted its stake in ICU Medical by 71.6% in the 1st quarter. Wellington Management Group LLP now owns 1,516,089 shares of the medical instruments supplier's stock valued at $337,542,000 after acquiring an additional 632,609 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in shares of ICU Medical by 2.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 342,453 shares of the medical instruments supplier's stock worth $76,248,000 after purchasing an additional 6,562 shares in the last quarter. Eaton Vance Management raised its stake in ICU Medical by 45.4% in the 1st quarter. Eaton Vance Management now owns 265,343 shares of the medical instruments supplier's stock valued at $59,077,000 after acquiring an additional 82,861 shares during the period. Finally, Northern Trust Corp raised its stake in ICU Medical by 5.7% in the 2nd quarter. Northern Trust Corp now owns 240,230 shares of the medical instruments supplier's stock valued at $39,491,000 after acquiring an additional 12,974 shares during the period. 90.20% of the stock is owned by institutional investors.
About ICU Medical
(Get Rating)
ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for hemodialysis catheters; and ChemoClave and ChemoLock closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs.
Recommended Stories
- Get a free copy of the StockNews.com research report on ICU Medical (ICUI)
- Broadcom Bounces From Institutional Bottom
- Affirm is the Underdog Starring in a Spaghetti Western
- Is Autozone A Buy Before Earnings Are Released?
- Is There Value in Verizon Shares at These Levels?
- MarketBeat Podcast: Stock Market, Bad News is Good News
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.
